ML 210, >=98% (HPLC)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

ML 210 has been used as a glutathione peroxidase 4 (GPX4) inhibitor to induce ferroptosis in cancer cells. It has also been used as a GPX4 inhibitor to examine whether pharmacological inhibition of GPX4 altered prominin2 expression and impacted ferroptosis in adherent MCF10A and Hs578t cells.

Biochem/physiol Actions

ML 210 acts as a selenoenzyme glutathione peroxidase 4 (GPX4) inhibitor. It exhibits cytotoxicity against few ovarian cancer cell lines.

ML 210 induces non-apoptotic cell death in tumor cells expressing the RAS oncogene.

Packaging

5, 25 mg in glass bottle